MORENA, VALENTINA
MORENA, VALENTINA
Universita' degli Studi di MILANO
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
2021 A. Giacomelli, F. Conti, L. Pezzati, L. Oreni, A.L. Ridolfo, V. Morena, C. Bonazzetti, G. Pagani, T. Formenti, M. Galli, S. Rusconi
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
2021 F. Borgonovo, M. Passerini, M. Piscaglia, V. Morena, A. Giacomelli, L. Oreni, G. Dedivitiis, A. Lupo, S. Falvella, M.V. Cossu, A.F. Capetti
Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients
2020 L. Milazzo, L. van den Bogaart, S. Sollima, L. Oreni, A. Lai, V. Morena, C. Bonazzetti, L. Ridolfo Anna, S. Antinori
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
2020 S. Antinori, C. Bonazzetti, G. Gubertini, A. Capetti, C. Pagani, V. Morena, S. Rimoldi, L. Galimberti, P. Sarzi-Puttini, A.L. Ridolfo
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study
2020 C. Bonazzetti, V. Morena, A. Giacomelli, L. Oreni, G. Casalini, L.R. Galimberti, M. Bolis, M. Rimoldi, E. Ballone, R. Colombo, A.L. Ridolfo, S. Antinori
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
2020 V. Morena, L. Milazzo, L. Oreni, G. Bestetti, T. Fossali, C. Bassoli, A. Torre, M.V. Cossu, C. Minari, E. Ballone, A. Perotti, D. Mileto, F. Niero, S. Merli, A. Foschi, S. Vimercati, G. Rizzardini, S. Sollima, L. Bradanini, L. Galimberti, R. Colombo, V. Micheli, C. Negri, A.L. Ridolfo, L. Meroni, M. Galli, S. Antinori, M. Corbellino
A case of crusted scabies with a delayed diagnosis and inadequate therapy
2020 C. Bonazzetti, G. Pagani, A. Giacomelli, V. Morena, C. Bassoli, M. Corbellino, G. Bestetti, L. Galimberti, R. Grande, S. Antinori
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: a retrospective cohort study
2020 A. Giacomelli, G. Pagani, A. Lisa Ridolfo, L. Oreni BIT, F. Conti, L. Pezzati, L. Bradanini, G. Casalini, C.R. Bassoli, V. Morena, S. Passerini, G. Rizzardini, C. Cogliati, E. Ceriani, R. Colombo, S. Rusconi, C. Gervasoni, D. Cattaneo, S. Antinori, M. Galli